Avalyn Pharma Inc. (NASDAQ:AVLN – Get Free Report) major shareholder Sr One Capital Management, Llc acquired 555,555 shares of Avalyn Pharma stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $18.00 per share, with a total value of $9,999,990.00. Following the completion of the purchase, the insider directly owned 2,186,562 shares in the company, valued at $39,358,116. This represents a 34.06% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Avalyn Pharma Trading Up 1.2%
AVLN stock traded up $0.35 during trading on Friday, reaching $29.84. The company’s stock had a trading volume of 830,048 shares. Avalyn Pharma Inc. has a 1 year low of $26.00 and a 1 year high of $30.20.
Read More
Receive News & Ratings for Avalyn Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalyn Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
